Daniel Sterman, MD, Pulmonology, New York, NY, NYU Langone Hospitals

DanielStermanMDFCCP

Pulmonology New York, NY

Critical Care Medicine, Interventional Pulmonology, Pleural Disease, Thoracic Oncology

Thomas & Suzanne Murphy Professor of Pulmonary & Critical Care Medicine Director, Division of Pulmonary, Critical Care & Sleep Medicine Director, Multidisciplinary Pulmonary Oncology Program Departments of Medicine & Cardiothoracic Surgery NYU Langone Medical Center

Overview of Dr. Sterman

Dr. Daniel Sterman is a pulmonologist in New York, NY and is affiliated with NYU Langone Hospitals. He received his medical degree from Weill Cornell Medical College of Cornell University and has been in practice 28 years. Dr. Sterman accepts several types of health insurance, listed below. He is one of 146 doctors at NYU Langone Hospitals who specialize in Pulmonology.

Education & Training

  • University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1997
  • University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
  • Weill Cornell Medical College of Cornell UniversityClass of 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2014 - 2022
  • PA State Medical License
    PA State Medical License 1991 - 2016
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Philadelphia Magazine Castle Connolly, 2005-2006, 2010-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Other

Authored Content

  • Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive ReviewFebruary 2018

Press Mentions

  • Can Vitamin D Help Fight COVID-19?
    Can Vitamin D Help Fight COVID-19?October 22nd, 2020
  • COVID-19 Pandemic Delays Mesothelioma Clinical Trials
    COVID-19 Pandemic Delays Mesothelioma Clinical TrialsApril 9th, 2020
  • Coronavirus: What Is Hydroxychloroquine - the Drug Trump Is Pushing to Treat COVID-19?
    Coronavirus: What Is Hydroxychloroquine - the Drug Trump Is Pushing to Treat COVID-19?April 8th, 2020
  • Join now to see all

Grant Support

  • Clinical Trials In MesotheliomaNational Cancer Institute2006–2010
  • Intrapleural Adenoviral-Mediated Interferon-Beta (Ifn-B) Gene TransferNational Center For Research Resources2005
  • Ifn-B Gene Transfer For Pleural MalignanciesNational Center For Research Resources2004
  • Upcc: Trial Of Intravenous Pv701 In PTS W Solid TumorsNational Center For Research Resources2000–2002
  • Upcc 5598: Gene Therapy Of Malignant Mesothelioma Using El/E4 Deleted AdenovirusNational Center For Research Resources2000–2002
  • Upcc#5597:A Phase I Trial Of El/E4 Deleted Ad.Rsvtk Virus W/ GanciclovirNational Center For Research Resources1999–2002
  • Gene Therapy Of Malignant Mesothelioma Using E1 Deleted AdenovirusNational Center For Research Resources1999–2000

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AmeriHealth Direct POS
    Amerihealth HMO
    AmeriHealth PPO
    BCBS Blue Card PPO
    Coventry Carelink Health Plans PPO
    First Health PPO
    Great West PPO
    HealthAmerica HealthAssurance PPO
    Horizon BCBS Direct Access
    Horizon BCBS HMO
    Horizon BCBS POS
    Horizon BCBS PPO
    Humana ChoiceCare Network PPO
    IBC Keystone HMO / POS
    IBC Personal Choice PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment